Intravenously injected insulin-like growth factor (IGF) I/IGF binding protein-3 complex exerts insulin-like effects in hypophysectomized, but not in normal rats

The Journal of Clinical Investigation
J ZapfE R Froesch

Abstract

Insulin-like growth factor (IGF) circulates in blood in two large molecular mass forms of 150 and 40 kD. Under normal conditions, most of the IGF is bound to the 150-kD complex by which it is retained in the circulation and therefore unable to exert acute insulin-like actions. The aim of this study was to answer the question whether or not IGF in the 40-kD complex is bioavailable to insulin target tissues and thus can cause acute insulin-like effects in vivo. Intravenously injected 1:1 molar recombinant human (rh) IGF I/rhIGF binding protein (BP)-3 complex lowered blood glucose and stimulated glycogen synthesis in diaphragm of hypophysectomized, but not of normal rats. The serum half-lives of the two components of the complex were similar to each other, but considerably shorter in hypox than in normal rats. On neutral gel filtration of serum both components of the injected complex appeared predominantly in the 150-kD region in normal rats. In hypox rats which lack the 150-kD complex they were found in the 40-kD region and disappeared rapidly from the circulation. We conclude that in the absence of the 150-kD complex, IGF associated with the 40-kD complex can rapidly leave the vascular compartment, reach insulin or type 1 IGF re...Continue Reading

References

Sep 1, 1975·Endocrinology·K L Cohen, S P Nissley
Sep 1, 1988·The Journal of Clinical Endocrinology and Metabolism·M Binoux, P Hossenlopp
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J ZapfE R Froesch
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R C Baxter, J L Martin
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·W H Daughaday, M Kapadia
Jul 16, 1987·The New England Journal of Medicine·H P GulerE R Froesch
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·H P GulerE R Froesch
Mar 1, 1984·Clinics in Endocrinology and Metabolism·J ZapfE R Froesch

❮ Previous
Next ❯

Citations

Mar 1, 1995·Trends in Endocrinology and Metabolism : TEM·J Zapf
Sep 17, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y R BoisclairG T Ooi
Nov 19, 2008·Antioxidants & Redox Signaling·George VardatsikosAshok K Srivastava
Sep 10, 2011·The Journal of Endocrinology·Ashley GrayColette Galet
Jan 15, 2009·European Journal of Endocrinology·Ana PokrajacPeter J Trainer
May 10, 2006·Journal of Endocrinological Investigation·A BarrecaR Lorini
Sep 4, 2012·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Ulrick EspelundJan Frystyk
Dec 14, 2011·Domestic Animal Endocrinology·J Frystyk
Dec 3, 2008·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Ying KuanJohn L Haylor
Sep 1, 2004·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Jan Frystyk
Sep 15, 2015·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Zdenek FrysakDavid Karasek
Nov 23, 2013·Expert Opinion on Therapeutic Targets·Rikke HjortebjergJan Frystyk
Apr 16, 2008·Expert Opinion on Therapeutic Targets·John S P Yuen, Valentine M Macaulay
Jun 1, 1996·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·N Mauras, M W Haymond
Jan 1, 1995·Progress in Growth Factor Research·S AdamsA Sommer
Jun 7, 2007·Journal of Animal Breeding and Genetics = Zeitschrift Für Tierzüchtung Und Züchtungsbiologie·S LiL Huang
Feb 15, 2007·The Journal of Clinical Endocrinology and Metabolism·Michael A NauckJürgen Zapf
Sep 20, 2002·Endocrinology·Josef V Silha, Liam J Murphy
Feb 9, 2000·American Journal of Physiology. Endocrinology and Metabolism·K R KritschD M Ney
Aug 30, 2007·The Journal of Clinical Endocrinology and Metabolism·Horacio M DomenéHéctor G Jasper
Aug 1, 1997·The American Journal of Physiology·M A BoroujerdiD L Russell-Jones
Dec 19, 2019·Frontiers in Neurology·Sylvia NieuwenhuisJeffrey C Glennon
Apr 9, 2021·Journal of Veterinary Internal Medicine·Eric ZiniClaudia E Reusch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.